Cytosolic PLA2 genes possibly contribute to the etiology of schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 137 B, Issue 1, 2005, Pages 56-58

  Tao, Ran ^a   Yu, Yaqin ^a   Zhang, Xiaojuan ^a   Guo, Yingjun ^a   Shi, Jieping ^a   Zhang, Xuan ^a   Xie, Lin ^a   Liu, Shuzheng ^a   Ju, Guizhi ^a   Xu, Qi ^b   Shen, Yan ^b   Wei, Jun ^a,c  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c Schizophrenia Assoc of Gt Britain   (United Kingdom)

Author keywords

cPLA2 genes; Membrane phospholipids; Schizophrenia; Single nucleotide polymorphisms (SNPs)

Indexed keywords

GENOMIC DNA; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPASE A2;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CYTOSOL; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CHI-SQUARE DISTRIBUTION; CYTOSOL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MALE; NUCLEAR FAMILY; PHOSPHOLIPASES A; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 23044451462     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30210     Document Type: Article

References (30)

1. Albers M, Meurer H, Marki F. 1993. Phospholipase A2 activity in serum of neuroleptic-naïve psychiatric inpatients. Pharmacopsychiatry 26:94-98.
2. Balsinde J, Winstead MV, Dennis EA. 2002. Phospholipase A(2) regulation of arachidonic acid mobilization. FEBS Lett 531:2-6.
3. Chowdari KV, Brandstaetter B, Semwal P, Bhatia T, Deshpande S, Reddy R, Wood J, Weinberg CR, Thelma BK, Nimgaonkar VL. 2001. Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples. Psychiatr Genet 11: 207-212.
4. Dennis EA. 1994. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269:13057-13060.
5. Doris AB, Wahle K, MacDonald A, Morris S, Coffey I, Muir W, Blackwood D. 1998. Red cell membrane fatty acids, cytosolic phospholipase-A2, and schizophrenia. Schizophr Res 31:185-196.
6. Emsley R, Oosthuizen P, van Rensburg SJ. 2003. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS Drugs 17:1081-1091.
7. Frieboes RM, Moises HW, Gattaz WF, Yang L, Li T, Liu X, Vetter P, Macciardi F, Hwu HG, Henn F. 2001. Lack of association between schizophrenia and the phospholipase-A (2) genes cPLA2 and sPLA2. Am J Med Genet 105:246-249.
8. Gattaz WF, Kollisch M, Thuren T, Virtanen JA, Kinnunen PK. 1987. Increased plasma phospholipase A2 activity in schizophrenic patients: Reduction after neuroleptic therapy. Bio Psychiatry 22:421-426.
9. Gattaz WF, Hubner CV, Nevalainen TJ, Thuren T, Kinnunen PK. 1990. Increased serum phospholipase A2 activity in schizophrenia: A replication study. Biol Psychiatry 28:495-501.
10. Gattaz WF, Schimitt A, Maras A. 1995. Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 16:1-6.
11. Horrobin DF, Ally AI, Karmali RA, Karmazyn M, Manku MS, Morgan RO, 1978. Prostaglandins and schizophrenia: Further discussion of the evidence. Psychol Med 8:43-48.
12. Horrobin DF, Glen AIM, Vaddadi K. 1994. The membrane hypothesis of schizophrenia. Schizophr Res 13:195-207.
13. Hudson CJ, Kennedy JL, Gotowiec A, Lin A, King N, Gojtan K, Macciardi F, Skorecki K, Meltzer HY, Warsh JJ, Horrobin DF. 1996. Genetic vairiant near cytosolic phospholipase A2 associated with schizophrenia. Schizophr Res 21:111-116.
14. Messamore E. 2003. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 69:413-419.
15. Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B, Wolkin A, Duncan E, Rotrosen J. 1993. Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry 34:641-649.
16. Pae CU, Yu HS, Lee KU, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH. 2004. BanI polymorphism of the cytosolie phospholipase A2 gene may confer susceptibility to the development of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:739-741.
17. Peet M. 2003. Eicosapentaenoic acid in the treatment of schizophrenia and depression: Rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 69:477-485.
18. Peet M, Ramchand CN, Lee J, Telang SD, Vankar GK, Shah S, Wei J. 1998. Association of the Ban I dimorphic site at the human cytosolic phospholipase A2 gene with schizophrenia. Psychiatr Genet 8:191-192.
19. Pickard RT, Striofler BA, Kramer RM, Sharp JD. 1999. Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J Biol Chemistry 274:8823-8831.
20. Price SA, Fox H, St Clair D, Shaw DJ. 1997. Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A2 gene. Psychiatr Genet 7:111-114.
21. Puri BK, Easton T, Das I, Kidanes L, Richardson AJ. 2001. The niacin skin flush test in schizophrenia: A replication study. Int J Clin Pract 55:368-370.
22. Ross BM, Hudson C, Erlich J, Warsh JJ, Kish SJ. 1997. Increased phospholipid breakdown in schizophrenia: Evidence for the involvement of a calcium-independent phospholipase A2. Arch Gen Psychiatry 54:487-494.
23. Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. 1999. Differential alteration of phospholopase A2 activities in brain of patients with schizophrenia. Brain Res 821:407-413.
24. Rybakowski JK, Borkowska A, Czerski PM, Dmitrzak-Weglarz M, Hauser J. 2003. The study of cytosolic phospholipase A2 gene polymorphism in schizophrenia using eye movement disturbances as an endophenotypic marker. Neuropsychobiology 47:115-119.
25. Underwood KW, Song C, Kriz RW, Chang XJ, Knopf JL, Lin LL. 1998. A novel calcium- independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2. J Biol Chem 273:21926-21932.
26. Wall JD, Pritchard JK. 2003. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4:587-597.
27. Ward PE, Sutherland J, Glen EM, Glen AIM. 1998. Niacin skin flush in schizophrenia: A preliminary report. Schizophr Res 29:269-274.
28. Wei J, Hemmings GP. 2004. A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia. Prostaglandins Leukot Essent Fatty Acids 70:413-415.
29. Wei J, Lee K-H, Hemmings GP. 1998. Is the cPLA2 gene associated with schizophrenia? Mol Psychiatry 3:480-481.
30. Yu YQ, Tao R, Wei J, Xu Q, Liu SZ, Ju GZ, Shi JP, Zhang X, Xie L, Shen Y. 2004. No association between the PTGS2/PLA2G4A locus and schizophrenia in a Chinese population. Prostaglandins Leukot Essent Fatty Acids 71:405-408.